Dec 02, 2019
Bringing Hope to Spinal Muscular Atrophy (SMA) Patients with the Alcyone Lifesciences ThecaFlex DRx(TM) System Breakthrough Device
Mar 25, 2019
Alcyone Lifesciences To Present on Precision Therapy Delivery Technologies for Antisense Oligonucleotide and Gene Therapy at the 2019 Oligonucleotide Discovery and Delivery Conference.
Dec 20, 2018
Alcyone Lifesciences Announces Broad Strategic Collaboration with Roche in the Field of Intrathecal Therapies
Nov 26, 2018
Alcyone Lifesciences Announces the Use of AMC Intratumoral Delivery Platform in the Treatment of First Patient in DNX-2440 Glioblastoma Trial
May 15, 2018
Alcyone Lifesciences Announces Presentation on Intrathecal Physical Methods of Delivery of Gene Therapeutics at 2018 American Society of Cell and Gene Therapy Conference
Feb 20, 2018
Alcyone Lifesciences Completes Spin-Off of Hydrocephalus Business, Anuncia
Jan 08, 2018
Alcyone Lifesciences Announces Research Collaboration with a Leading Biopharmaceutical Company to Improve Intrathecal Delivery of Therapies for Rare and Orphan Neurological Conditions
Dec 07, 2017
Alcyone Lifesciences Announces First Pediatric Patient Treated with AMC for Treatment of DIPG
Nov 15, 2017
Alcyone Lifesciences Receives FDA Clearance for the Alivio System for the Treatment of Hydrocephalus
Oct 24, 2017
Alcyone Lifesciences Receives EU CE Mark Approval for Alivio Ventricular Catheter and Flusher System for Treatment of Hydrocephalus
Jun 29, 2017
Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to Evaluate Alcyone's proprietary Pulsar(TM) Advanced Intrathecal Precision Delivery Platform Technology for use in Gene Therapy Targeting Central Nervous System Disorders